Global EPA & DHA (Omega 3) Ingredients Industry Research Report, Growth Trends and Competitive Analysis 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global EPA & DHA (Omega 3) Ingredients Industry Research Report, Growth Trends and Competitive Analysis 2024-2034
IOI’s range of MARIS OMEGA-3 ingredients helps making great products healthier, offering all the well-documented benefits of EPA and DHA for the cardiovascular and the nervous system. MARIS OMEGA-3 is manufactured “fresh as sushi”, making use of innovative production technology to reach lowest oxidation levels. 100 % neutral in taste and smell, MARIS OMEGA-3 provides superior sensory properties and stability for food applications.
The global EPA & DHA (Omega 3) Ingredients market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
Omega-3s are considered a healthy fat that is critical to our brain and heart function, as well as our overall well-being. Our bodies cannot produce Omega-3s on its own at significant levels, so as a result, it is essential that we consume this type of fat in our daily diet. Omega-3 fatty acids are one of the most well studied nutrients in the world, with more than 30,000 scientific studies and published papers over the past 35 years demonstrating that Omega-3's can deliver valuable health benefits at every life stage – from before birth and into your senior years. Omega-3 is found mainly in marine fish, as well as algae and certain plants. Today, fish is our major dietary source of both Omega-3 EPA and DHA – the dynamic duo of fatty acid nutrients. Omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) help to support overall health across every system in the body – from brain and eye development in infants, to the maintenance of cardiovascular health in adults and seniors. Europe, led by France and Germany omega 3 ingredient market, is anticipated to witness an annual growth over 2017-2023. Asia Pacific omega 3 ingredient market size is expected to grow significantly, owing to increase in consumer spending, ageing population, and the demand across dietary supplements application. China and Japan omega 3 ingredients market led the regional growth of APAC, with China dominating the dietary supplement application.
In terms of sales (consumption) side, this report focuses on the sales of EPA & DHA (Omega 3) Ingredients by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global EPA & DHA (Omega 3) Ingredients market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global EPA & DHA (Omega 3) Ingredients market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
Omega Protein
DSM
BASF
Axellus
Martek
Aker BioMarine
Algae EPAX
Lonza
GC Rieber Oils
Croda
By Type
Anchovy/Sardine
Cod Liver Oil
Salmon Oil
Algae Oil
High Concentrates
Medium Concentrates
Low Concentrates
By Application
Dietary Supplements
Functional Foods
Pharmaceuticals
Pet & Animal Feed
Infant Formulas
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of EPA & DHA (Omega 3) Ingredients in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of EPA & DHA (Omega 3) Ingredients manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EPA & DHA (Omega 3) Ingredients sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.
The global EPA & DHA (Omega 3) Ingredients market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
Omega-3s are considered a healthy fat that is critical to our brain and heart function, as well as our overall well-being. Our bodies cannot produce Omega-3s on its own at significant levels, so as a result, it is essential that we consume this type of fat in our daily diet. Omega-3 fatty acids are one of the most well studied nutrients in the world, with more than 30,000 scientific studies and published papers over the past 35 years demonstrating that Omega-3's can deliver valuable health benefits at every life stage – from before birth and into your senior years. Omega-3 is found mainly in marine fish, as well as algae and certain plants. Today, fish is our major dietary source of both Omega-3 EPA and DHA – the dynamic duo of fatty acid nutrients. Omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) help to support overall health across every system in the body – from brain and eye development in infants, to the maintenance of cardiovascular health in adults and seniors. Europe, led by France and Germany omega 3 ingredient market, is anticipated to witness an annual growth over 2017-2023. Asia Pacific omega 3 ingredient market size is expected to grow significantly, owing to increase in consumer spending, ageing population, and the demand across dietary supplements application. China and Japan omega 3 ingredients market led the regional growth of APAC, with China dominating the dietary supplement application.
In terms of sales (consumption) side, this report focuses on the sales of EPA & DHA (Omega 3) Ingredients by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global EPA & DHA (Omega 3) Ingredients market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global EPA & DHA (Omega 3) Ingredients market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
By Company
Omega Protein
DSM
BASF
Axellus
Martek
Aker BioMarine
Algae EPAX
Lonza
GC Rieber Oils
Croda
By Type
Anchovy/Sardine
Cod Liver Oil
Salmon Oil
Algae Oil
High Concentrates
Medium Concentrates
Low Concentrates
By Application
Dietary Supplements
Functional Foods
Pharmaceuticals
Pet & Animal Feed
Infant Formulas
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of EPA & DHA (Omega 3) Ingredients in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of EPA & DHA (Omega 3) Ingredients manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EPA & DHA (Omega 3) Ingredients sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.